机构

• 广州生物医药与健康研... [4]

采集方式

• OAI收割 [4]

内容类型

• 期刊论文 [4]

发表日期

• 2016 [2]
• 2014 [2]

学科主题

• Cell Biolo... [2]
• Oncology [2]
• Science & ... [2]

筛选

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 专题：广州生物医药与健康研究院    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 A microRNA-mediated decrease in eukaryotic initiation factor 2 alpha promotes cell survival during PS-341 treatment 期刊论文  OAI收割 SCIENTIFIC REPORTS, 2016, 卷号: 6 Jiang, Lili; Zang, Dan; Yi, Songgang; Li, Xiaofen; Yang, Changshan; Dong, Xiaoxian; Zhao, Chong; Lan, Xiaoying; Chen, Xin; Liu, Shouting; Liu, Ningning; Huang, Hongbiao; Shi, Xianping; Wang, Xuejun; Liu, Jinbao 收藏  |  浏览/下载：34/0  |  提交时间：2016/12/16 A microRNA-mediated decrease in eukaryotic initiation factor 2 alpha promotes cell survival during PS-341 treatment 期刊论文  OAI收割 SCIENTIFIC REPORTS, 2016, 卷号: 6 作者:  Liu, Ningning;  Liu, Jinbao;  Wang, Xuejun;  Shi, Xianping;  Huang, Hongbiao   |  收藏  |  浏览/下载：26/0  |  提交时间：2018/12/13 Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth 期刊论文  OAI收割 ONCOTARGET, 2014, 卷号: 5, 期号: 14, 页码: 5453-5471 作者:  Lan, Xiaoying;  Song, Wenbin;  Lu, Xiaoyu;  Liu, Shouting;  Liu, Jinbao   |  收藏  |  浏览/下载：28/0  |  提交时间：2018/12/13 Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth 期刊论文  OAI收割 ONCOTARGET, 2014, 卷号: 5, 期号: 14, 页码: 5453-5471 Liu, Ningning; Li, Xiaofen; Huang, Hongbiao; Zhao, Chong; Liao, Siyan; Yang, Changshan; Liu, Shouting; Song, Wenbin; Lu, Xiaoyu; Lan, Xiaoying; Chen, Xin; Yi, Songgang; Xu, Li; Jiang, Lili; Zhao, Canguo; Dong, Xiaoxian; Zhou, Ping; Li, Shujue; Wang, Shunqing; Shi, Xianping; Dou, Ping Q.; Wang, Xuejun; Liu, Jinbao 收藏  |  浏览/下载：45/0  |  提交时间：2016/12/16